Rutgers Cancer Institute | Strategic Alliance Partners
Latest from Rutgers Cancer Institute
From radiopharmaceuticals to hypofractionated radiation therapy, one expert explained the current landscape of radiation treatments for prostate cancer.
One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma.
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
26 Years of Resilience: Overcoming Rare Blood Cancer and Severe GVHD
3
Uterine Cancer Story: From Emergency Surgery to Pelvic Radiation Recovery
4
When Insurance Says No: How Patients Can Fight Back Against Cancer Treatment Denials
5